Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
2.590
-0.130 (-4.78%)
Dec 20, 2024, 4:00 PM EST - Market closed

Company Description

Gelteq Limited focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals.

It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products.

Gelteq Limited was incorporated in 2017 and is headquartered in Caulfield, Australia.

Gelteq Limited
Gelteq logo
Country Australia
Founded 2018
IPO Date Oct 29, 2024
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 8
CEO Nathan Givoni

Contact Details

Address:
639-641 Glenhuntly Road
Caulfield, VIC 3162
Australia
Phone 61 3 9087 3990
Website gelteq.com

Stock Details

Ticker Symbol GELS
Exchange NASDAQ
Fiscal Year July - June
Reporting Currency AUD
IPO Price $4.00
CIK Code 0001920092
SIC Code 2834

Key Executives

Name Position
Nathan Jacob Givoni Co-Founder, Chief Executive Officer and Director
Simon Hayden Szewach Co-Founder and Executive Chairman
Anthony W. Panther A.C.I.S., AGIA, B.E., C.A., L.L.B., LL.B Chief Financial Officer
Craig J. Young Chief Financial Officer and Company Secretary

Latest SEC Filings

Date Type Title
Nov 15, 2024 20-F Annual and transition report of foreign private issuers
Oct 31, 2024 NT 20-F Notification of inability to timely file Form 20-F
Oct 30, 2024 6-K Report of foreign issuer
Oct 28, 2024 CERT Certification by an exchange approving securities for listing
Oct 22, 2024 424B4 Prospectus
Oct 17, 2024 8-A12B Registration of securities
Sep 30, 2024 EFFECT Notice of Effectiveness
Sep 25, 2024 F-1/A [Amend] Registration statement for certain foreign private issuers
Sep 20, 2024 UPLOAD Filing
Sep 12, 2024 F-1/A [Amend] Registration statement for certain foreign private issuers